Technology | March 29, 2011

FDA Clears Wireless Point-of-Care Blood Testing System

March 29, 2011 – The U.S. Food and Drug Administration (FDA) cleared a wireless point-of-care testing system that allows real time transmission of diagnostic test results generated directly from the patient bedside.

The new i-Stat 1 wireless handheld, from Abbott, offers several types of test cartridges, including a cardiac troponin test. Blood is added to disposable cartridges that contain test reagents. The cartridge is then inserted in the analyzer and results are provided in minutes. In addition to cardiac markers, other tests include chemistries, blood gases, electrolytes and tests for lactate, hemoglobin, coagulation and hematology.

"With i-Stat 1 Wireless, caregivers are able to share critical test information electronically without leaving the patient's bedside," said Greg Arnsdorff, head of Abbott's point of care business. "By empowering nurses to stay at the bedside, the new i-Stat 1 Wireless supports a patient-focused approach to treatment, allowing for expedited decision making that helps minimize time to treatment."

The handheld analyzer can potentially save time by allowing caregivers to perform critical tests at the bedside and then transmit test results immediately. Physicians can then review the results from anywhere they have access to electronic records. Eliminating back-and-forth movement from the bedside to a desktop transmission terminal somewhere in the department gives staff the ability to better focus on the patient.

"With wireless, physicians can receive immediate test information in the electronic medical record, enabling them to act quickly when a patient's clinical status is rapidly changing," Arnsdorff said.

With the 10-minute cardiac troponin test cartridge, for example, emergency department staff can test, transmit and treat from the bedside. This helps healthcare providers maintain compliance with testing guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA), which call for a turnaround time of less than 60 minutes. By sharing these test results via a hospital's existing wireless network, caregivers have rapid access to information that can help determine if a patient is having a heart attack.

The device is certified for compatibility with existing wireless networks. It is also is compatible with point-of-care data management systems used with earlier versions of the i-Stat System.

For more information: www.abbottpointofcare.com

Related Content

Intact Vascular, TOBA clinical study, one-year results, Tack Endovascular System, Journal of Vascular Surgery
News | Peripheral Arterial Disease (PAD)| August 24, 2016
Intact Vascular Inc. announced that the one-year results from its Tack Optimized Balloon Angioplasty (TOBA) clinical...
Mayo Clinic, blood test, heart attack risk, plasma ceramides
News | Cardiac Diagnostics| August 24, 2016
August 24, 2016 — Mayo Clinic has launched a new type of ...
Technavio report, renal denervation devices, 2015
News | Renal Denervation| August 23, 2016
August 23, 2016 — Technavio analysts forecast the global...
Jason Burdick, injectable hydrogels, heart failure, heart attack, American Chemical Society

Compared to other types of hydrogels being developed (left), a new hydrogel (right) can form crosslinks after injection into the heart, making the material stiffer and longer-lasting. Image courtesy of American Chemical Society.

News | Heart Failure| August 23, 2016
August 23, 2016 — During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells within
News | Peripheral Arterial Disease (PAD)| August 22, 2016
Avinger Inc. recently announced the closing of its previously announced public offering of 9,857,800 shares of Avinger’...
DMC Heart Hospital, Detroit Medical Center, complex percutaneous intervention education course, PCI, cath lab training
News | Cath Lab| August 22, 2016
The Detroit Medical Center (DMC) Heart Hospital recently completed a Complex Percutaneous Intervention education course...
TAILOR-PCI study, antiplatelet medication, genotype, NHLBI grant
News | Antiplatelet and Anticoagulation Therapies| August 18, 2016
Researchers at the Peter Munk Cardiac Centre, Toronto, and at Mayo Clinic are leading the Tailored Antiplatelet Therapy...
Covidien, Medtronic, TurboHawk, Atherectomy system

The Medtronic TurboHawk atherectomy system. 

Feature | Atherectomy Devices| August 18, 2016 | Dave Fornell
Due to poor outcomes from percutaneous transluminal angioplasty (PTA) ballooning of vessels alone, or of stenting in
Sapien III, Sapien 3, PARTNER III, FDA approval, expanded indication, intermediate risk patients

The Sapien 3 valve has a skirt of fabric at its base that has significantly reduced issues of paravalvular leak, which was an issue with the first generation Sapien device. 

Feature | Heart Valve Technology| August 18, 2016 | Dave Fornell
August 18, 2016 — The U.S.
Corindus Corpath, Acist Medical RXi and CVi, Fairview Southdale Hospital, Minnesota, cath lab
News | Cath Lab| August 17, 2016
Corindus Vascular Robotics Inc. and Acist Medical Systems Inc. are providing Fairview Southdale Hospital, Edina, Minn...
Overlay Init